Delisting risk
CDT · NASDAQ · Biotechnology

CDT Equity (CDT)

Develops and out-licenses repurposed clinical assets through solid-form chemistry, computational analysis, and patent creation.

$0.8888
Pre-market−0.03 (−3.17%)
At close$0.9179(−37.98%)

Breakdown13F · 13D/G · Form 4

Institutions381 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail≈ 852.36%4.14M shares
Insiders7 holders · as of Sep 2, 20261,176.66%5.72M shares
Strategic holders1 holder · as of May 7, 20250.01%62 shares
Adds to2,029.03%

485.8K company shares as of Aug 26, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (39.08M in the company's Sep 3, 2026 report, 485.8K elsewhere); stakes use the report.

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 2,029.03%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Andrew Regan1Insiderdirector, officer: Chief Executive Officer
1,171.78%5.69MForm 4filed Sep 2, 2026
BlackRock, Inc.Institution
105.83%5.14M13Fas of Jun 30, 2026
FMR LLCInstitution
83.28%4.05M13Fas of Jun 30, 2026
Price T Rowe Associates Inc /MD/Institution
71.45%3.47M13Fas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
56.78%2.76M13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution
36.09%1.75M13Fas of Jun 30, 2026
State Street CorpInstitution
30.97%1.50M13Fas of Jun 30, 2026
Wellington Management Group LLPInstitution
29.46%1.43M13Fas of Jun 30, 2026
Fuller & Thaler Asset Management, Inc.Institution
24.21%1.18M13Fas of Jun 30, 2026
Dimensional Fund Advisors LPInstitution
23.21%1.13M13Fas of Jun 30, 2026
Geode Capital Management, LLCInstitution
21.95%1.07M13Fas of Jun 30, 2026
Invesco Ltd.Institution
17.45%847,99713Fas of Jun 30, 2026
Channing Capital Management, LLCInstitution
15.65%760,12913Fas of Jun 30, 2026
Allspring Global Investments Holdings, LLCInstitution
13.70%665,73613Fas of Jun 30, 2026
Macquarie Management Holdings, Inc.Institution
11.27%547,36013Fas of Jun 30, 2026
Segall Bryant & Hamill, LLCInstitution
10.92%530,66113Fas of Jun 30, 2026
Victory Capital Management IncInstitution
10.30%500,22813Fas of Jun 30, 2026
Charles Schwab Investment Management IncInstitution
10.28%499,42913Fas of Jun 30, 2026
Sixth Street Partners Management Company, L.P.Institution
10.28%499,42913Fas of Jun 30, 2026
Northern Trust CorpInstitution
10.17%494,15313Fas of Jun 30, 2026
Arrowstreet Capital, Limited PartnershipInstitution
9.01%437,62613Fas of Jun 30, 2026
Marshall Wace, LLPInstitution
8.76%425,76713Fas of Jun 30, 2026
Morgan StanleyInstitution
8.55%415,45313Fas of Jun 30, 2026
Boston PartnersInstitution
8.03%389,99413Fas of Jun 30, 2026
Norges BankInstitution
8.02%389,74313Fas of Jun 30, 2026
  1. Andrew Regan reports a block also reported by Dimensional Fund Advisors LP; it is counted once, under Dimensional Fund Advisors LP.

13F — a manager's quarterly holdings · Form 4 — an insider's transaction report

Institutions13F, as of Mar 31, 2026

HolderShares% outstandingChg q/qFiled
Tower Research Capital LLC (TRC)1100.02%+110newMay 15, 2026
Morgan Stanley20.00%+2newMay 15, 2026

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Andrew Reganincl. Algo Holdings, Inc., Corvus Capital Ltd.31.56%13D/ASep 19, 2024
Sarborg Ltd16.40%13GMay 7, 2025
Ascent Partners Fund LLC9.90%13GJun 5, 2026
A.G.P. / Alliance Global Partners, LLC9.80%13GMay 15, 2025
Limitedincl. Rowland Master Trust8.30%13G/AOct 7, 2024

Insider tradesForm 4

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 28, 2026
Andrew Regandirector, officer: Chief Executive Officer
Sale290$0.00015,692,933
Jun 18, 2026
Mark Andrew Taylor10 percent owner
Sale · 4 lots2,068,000$1.420

CongressHouse and Senate disclosures

Not reported.